The global pandemic of COVID-19 has heightened public awareness of public health and epidemic prevention. Nanopore sequencing devices, with their compact size, portability, and ease of operation, enable sample testing at the bedside or in field settings, meeting the demand for rapid on-site detection. This capability supports real-time outbreak monitoring, rapid pathogen diagnosis, and contributes to effective control of infectious disease outbreaks.